HU198685B - Process for production of new derivatives of indoline - Google Patents

Process for production of new derivatives of indoline Download PDF

Info

Publication number
HU198685B
HU198685B HU873020A HU302087A HU198685B HU 198685 B HU198685 B HU 198685B HU 873020 A HU873020 A HU 873020A HU 302087 A HU302087 A HU 302087A HU 198685 B HU198685 B HU 198685B
Authority
HU
Hungary
Prior art keywords
formula
compound
solution
ethanol
ethyl
Prior art date
Application number
HU873020A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT46891A (en
Inventor
Keith Mills
Colin D Eldred
Alexander W Oxford
Ian H Coates
David E Bays
Colin F Webb
Michael D Dowle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to HU873020A priority Critical patent/HU198685B/hu
Publication of HUT46891A publication Critical patent/HUT46891A/hu
Publication of HU198685B publication Critical patent/HU198685B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU873020A 1986-01-08 1987-07-03 Process for production of new derivatives of indoline HU198685B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU873020A HU198685B (en) 1986-01-08 1987-07-03 Process for production of new derivatives of indoline

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868600397A GB8600397D0 (en) 1986-01-08 1986-01-08 Chemical compounds
HU873020A HU198685B (en) 1986-01-08 1987-07-03 Process for production of new derivatives of indoline

Publications (2)

Publication Number Publication Date
HUT46891A HUT46891A (en) 1988-12-28
HU198685B true HU198685B (en) 1989-11-28

Family

ID=10591074

Family Applications (1)

Application Number Title Priority Date Filing Date
HU873020A HU198685B (en) 1986-01-08 1987-07-03 Process for production of new derivatives of indoline

Country Status (23)

Country Link
US (1) US4855314A (enExample)
EP (1) EP0240096A1 (enExample)
JP (1) JPS62228056A (enExample)
KR (1) KR870007116A (enExample)
CN (1) CN1030409A (enExample)
AU (1) AU597325B2 (enExample)
BE (1) BE1000071A4 (enExample)
CH (1) CH672637A5 (enExample)
DE (1) DE3700408A1 (enExample)
DK (1) DK8787A (enExample)
FI (1) FI870062A7 (enExample)
FR (1) FR2595351B1 (enExample)
GB (2) GB8600397D0 (enExample)
HU (1) HU198685B (enExample)
IL (1) IL81201A (enExample)
IT (1) IT1205849B (enExample)
LU (1) LU86732A1 (enExample)
NL (1) NL8700026A (enExample)
NO (1) NO870075L (enExample)
NZ (1) NZ218868A (enExample)
PH (1) PH24741A (enExample)
PT (1) PT84075B (enExample)
ZA (1) ZA87105B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8724912D0 (en) 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8823731D0 (en) * 1988-10-10 1988-11-16 Smith Kline French Lab Biologically active compounds
CZ288351B6 (en) * 1990-06-07 2001-05-16 Astrazeneca Ab Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
CA2124206C (en) * 1991-11-25 2001-02-27 John Eugene Macor Indole derivatives
TW288010B (enExample) * 1992-03-05 1996-10-11 Pfizer
AU670579B2 (en) 1992-04-07 1996-07-25 Pfizer Inc. Indole derivatives as 5-HT1 agonists
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
EP0635015B1 (en) * 1992-04-10 1997-01-29 Pfizer Inc. Acylaminoindole derivatives as 5-ht1 agonists
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
TW251284B (enExample) * 1992-11-02 1995-07-11 Pfizer
FR2707639B1 (fr) * 1993-06-30 1995-10-13 Pf Medicament Nouveaux composés indoliques dérivés d'arylamines comme ligands sélectifs des récepteurs 5HT1D et 5HT1B.
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
AU686654B2 (en) * 1993-08-31 1998-02-12 Pfizer Inc. 5-arylindole derivatives
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
FR2749846B1 (fr) * 1996-06-17 1998-09-11 Pf Medicament Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
EP1311478B1 (en) * 2000-08-21 2006-06-07 Pacific Corporation Novel (thio)urea compounds and the pharmaceutical compositions containing the same
SI1517909T1 (sl) 2002-06-21 2007-06-30 Suven Life Sciences Ltd Novi tetraciklični arilkarbonil indoli, ki imajo afiniteto za serotoninski receptor, uporabni kot terapevtska sredstva, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
ES2297216T3 (es) * 2002-06-21 2008-05-01 Suven Life Sciences Limited Indoles tetraciclicos arilsulfonil que tienen afinidad con el receptor de la serotonina.
BR0312175A (pt) * 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
US7507835B2 (en) 2002-11-28 2009-03-24 Suven Life Sciences Ltd. N-arylsulfonyl-3-aminoalkoxyindoles
ATE401307T1 (de) * 2002-11-28 2008-08-15 Suven Life Sciences Ltd N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
JP4571507B2 (ja) * 2002-12-18 2010-10-27 スベン ライフ サイエンシズ リミティド セロトニン受容体親和性を有する四環系３−置換インドール
CA2508290C (en) * 2002-12-20 2017-02-28 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
AU2007257882B2 (en) 2006-06-12 2011-09-08 Secura Bio Inc. Process for making salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
DK157995C (da) * 1980-08-12 1990-08-06 Glaxo Group Ltd Analogifremgangsmaade til fremstilling af indolderivater
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
IT1205849B (it) 1989-03-31
GB8600397D0 (en) 1986-02-12
PH24741A (en) 1990-10-01
EP0240096A1 (en) 1987-10-07
NO870075D0 (no) 1987-01-08
GB2185020A (en) 1987-07-08
US4855314A (en) 1989-08-08
KR870007116A (ko) 1987-08-14
IL81201A0 (en) 1987-08-31
CN1030409A (zh) 1989-01-18
IT8747507A0 (it) 1987-01-08
FR2595351A1 (fr) 1987-09-11
GB8700382D0 (en) 1987-02-11
FR2595351B1 (fr) 1990-07-13
JPS62228056A (ja) 1987-10-06
NZ218868A (en) 1990-04-26
DE3700408A1 (de) 1987-07-09
PT84075A (en) 1987-02-01
ZA87105B (en) 1987-09-30
NL8700026A (nl) 1987-08-03
IL81201A (en) 1991-06-10
FI870062A0 (fi) 1987-01-08
CH672637A5 (enExample) 1989-12-15
GB2185020B (en) 1990-05-16
PT84075B (pt) 1989-07-31
HUT46891A (en) 1988-12-28
LU86732A1 (fr) 1988-02-02
FI870062A7 (fi) 1987-07-09
NO870075L (no) 1987-07-09
DK8787A (da) 1987-07-09
DK8787D0 (da) 1987-01-08
AU597325B2 (en) 1990-05-31
AU6742087A (en) 1987-07-09
BE1000071A4 (fr) 1988-02-02

Similar Documents

Publication Publication Date Title
WO2021023247A1 (en) Kras mutant protein inhibitor
RU2135477C1 (ru) Производные 1-бензолсульфонил-1,3-дигидро-2н-бензимидазол-2-она, способ их получения, содержащая их фармацевтическая композиция
AU597325B2 (en) Substituted indoles
EP0950047B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
US4894387A (en) 5-Substituted-3-aminoalkyl indole derivatives
SK404091A3 (en) Indole derivatives, method of production and pharmaceutical agents containing them
CZ280530B6 (cs) Indolový derivát, způsob výroby a farmaceutické prostředky s jeho obsahem
SK404291A3 (en) INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION COMPRISING THEMì (54) AND THEIR USE
HUT68927A (en) Process for producing indoline derivatives and pharmaceutical compositions containing them
HU196752B (en) Process for production of medical compositions containing indole-derivatives and these compounds
HU219974B (hu) Heterociklusos csoporttal helyettesített indolszármazék, előállítása és a vegyületet hatóanyagként tartalmazó gyógyszerkészítmények
EP0752985A1 (en) Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
JPH08507092A (ja) バソプレシンおよび／またはオシトシン作動薬および／または拮抗薬としての窒素基によって３位において置換されている１，３−ジヒドロインドール−２−オン誘導体
HUT68642A (en) N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
EP0820444A1 (fr) 1-phenylpyrazole-3-carboxamides actifs sur les recepteurs de la neurotensine
SK284546B6 (sk) Indolín-2-ónové deriváty, spôsob ich výroby, medziprodukt, farmaceutický prostriedok obsahujúci tieto deriváty a použitie týchto derivátov ako liečiv
CZ20014496A3 (cs) Indolové deriváty a jejich pouľití pro léčení osteoporózy
EA009051B1 (ru) О-замещенные гидроксиарильные производные
FR2722190A1 (fr) Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
CZ294233B6 (cs) Acylaminoalkenylenamidové deriváty, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
BE1000072A4 (fr) Derives de l'indole utiles comme medicaments et procede et intermediaires pour leur preparation.
CN104640860B (zh) 氮杂二氢吲哚
PT94070A (pt) Processo para a preparacao de derivados de piperazina
PL191633B1 (pl) Pochodne indolu i kompozycja farmaceutyczna zawierająca pochodną indolu
US4780477A (en) Isatin compositions having anti-ulcer activities

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee